Specialty & Oncology November 2018
CAR-T Cells: Driving a New Era of Oncology Immunotherapy
The innovation of CD19-directed chimeric antigen receptor T cells has paved the way for a novel therapeutic approach to the management of some relapsed and refractory B-cell leukemias and lymphomas.
Management of Bleeding in Patients Treated With Direct Oral Anticoagulants
With no need for frequent blood monitoring and fewer drug and dietary interactions, DOACs present advantages over vitamin K antagonists.
Why We Need Standardized Performance Measures in Specialty Practice
Specialty pharmacies should look to endorsed quality measures that provide a consistent and standard evaluation of performance.
Continuing Education
$7.95 Per CE Exam or $69 for 12 Lessons
-
• April 2026 • 2.00 Credits
Managing HIV Coinfections and Complications
-
Pain Management • March 2026 • 2.00 Credits
Updated Guidance for Opioid Use in Pain Management
-
Cardiovascular • February 2026 • 2.00 Credits
Managing Modifiable Risk Factors in Chronic Coronary Disease
Copyright © 2000 - 2024 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.